NASDAQ : FLSC
Frazier Life Sciences Acquisition Corp. II — Company profile
Financials · Shell Companies · United States
Last price 10.17 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 98.39M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Frazier Life Sciences Acquisition Corp II focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2026 and is based in Palo Alto, California.
Details
| Name | Frazier Life Sciences Acquisition Corp II |
| Sector | Financials |
| Industry | Shell Companies |
| Founded | 2026 |
| Ipo Date | 2026-10-14 |
| Ceo | Albert Cha |
| Country | United States |
| Exchange | NASDAQ |
| Reporting Currency | USD |
| Ipo Price | 10.00 |
| Isin | KYG371031017 |
| Cik | 2153598 |
| Sic | 6770 |
| Share Class | Class A Shares |
Key executives
| Name | Title |
|---|---|
| Albert Cha, M.D., Ph.D. | Chief Executive Officer and Director |
| Fran Adams | Chief Financial Officer |
| Kevin Li, M.D. | Chief Business Officer |
| Ali Jackson, J.D. | General Counsel |
| William C. Fairey, Jr. | Director |
| Benjamin L. Palleiko | Director, Chairman |
| R. Scott Struthers, Ph.D. | Director |
Contact
| Address | 1001 Page Mill Road, Building 4, Suite 200B, Palo Alto, California 94304, United States |
| Phone | 650 325 5156 |